<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00004796</url>
  </required_header>
  <id_info>
    <org_study_id>199/11934</org_study_id>
    <secondary_id>NU-523</secondary_id>
    <nct_id>NCT00004796</nct_id>
  </id_info>
  <brief_title>Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Office of Rare Diseases (ORD)</source>
  <brief_summary>
    <textblock>
      OBJECTIVES: I. Assess the effect of lactulose on the circadian rhythm of plasma melatonin in
      patients with subclinical hepatic encephalopathy.

      II. Assess the intrasubject variability of circadian melatonin levels and neuropsychological
      tests.

      III. Assess which elements of the neuropsychological test battery show the response to
      lactulose.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROTOCOL OUTLINE: Patients are alternately assigned to 1 of 2 treatment groups: no therapy
      for 3 weeks followed by lactulose for 3 weeks versus lactulose for 3 weeks followed by no
      therapy for 3 weeks.

      A dietician advises patients on a 1 g/kg per day protein diet. The lactulose dose is adjusted
      to result in 2 or 3 loose bowel movements per day.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 1994</start_date>
  <completion_date>February 1997</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <enrollment>16</enrollment>
  <condition>Portal Hypertension</condition>
  <condition>Hepatic Encephalopathy</condition>
  <condition>Cirrhosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lactulose</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        PROTOCOL ENTRY CRITERIA:

        --Disease Characteristics--

          -  Clinical diagnosis of cirrhosis with portal hypertension or portal-systemic shunting

        --Prior/Concurrent Therapy--

          -  No concurrent therapy for hepatic encephalopathy

        --Patient Characteristics--

          -  Age: Under 65

          -  Performance status: Not specified

          -  Hematopoietic: Not specified

          -  Hepatic: See Disease Characteristics

          -  Renal: Not specified

          -  Other: No alcohol intake within 1 month prior to entry No requirement for beta
             blockers No requirement for corticosteroids Not in intercontinental travel
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andres Blei</last_name>
    <role>Study Chair</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <verification_date>February 1998</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2000</study_first_submitted>
  <study_first_submitted_qc>February 24, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2000</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <keyword>cardiovascular and respiratory diseases</keyword>
  <keyword>cirrhosis</keyword>
  <keyword>gastrointestinal disorders</keyword>
  <keyword>hypertensive disorder</keyword>
  <keyword>portal hypertension</keyword>
  <keyword>rare disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Hepatic Encephalopathy</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactulose</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

